There is growing scientific evidence that suggests that the earlier an HIV positive person starts treatment, the better the chances that he or she will live a long, healthy and productive life.

Still, many challenges hamper the achievement of universal HIV treatment in Kenya. The good news is that data analysis shows that the challenges are not insurmountable. The benefits of starting antiretroviral therapy early far outweigh the initial cost of scaling up treatment. Such benefits go to the individual and the country broadly. This picture of the pandemic helps Kenyans appreciate the most sensible response to the virus.

Antiretroviral coverage in Kenya

72 percent of adults and 31 percent of children who have a DC4 cell count (immunity level) of less...

Social benefits of ARVs

Universal access to HIV results in significant reduction in Aids-related deaths and a decline in...

The economic effects of access to ARVs

The macroeconomic impacts of universal access to antiretroviral therapy are immense.

The cost of HIV treatment

A cohort study in three rural outpatient clinics in Kenya found that it costs about Sh1,800 (less...

Long-term cost savings

Internews Data Portal Long-term cost savings